Substituted pyrazinone derivatives as alpha2c-adrenoreceptor antagonists
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- JANSSEN PHARMA NV
- Publication Date
- 2009-01-14
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to selective α 2C - Adrenergic receptor antagonist activity as well as substituted pyrazinone derivatives having 5-HT reuptake inhibitory activity. The invention also relates to their preparation, pharmaceutical compositions comprising said derivatives and their use as medicaments, in particular for the treatment of diseases of the central nervous system. Background of the invention
[0002] Adrenoceptors form the binding site between the endogenous catecholamines epinephrine and norepinephrine and numerous target cells in the body that mediate the biological effects of the sympathetic nervous system. They are divided into three main subtypes, α 1 、α 2 and beta 3 . So far, nine different subtypes of adrenaline have been cloned from several species: α 1A 、α 1B 、α 1D 、α 2A 、α 2B 、α 2C , β 1 , β 2 and beta 3 . (Hieble, J.P. et al. J. Med. Chem. 1995, 38, 3415-3444). Available α 2 Ligands are only marginally s...